News about "Merck Partners with Blackstone "

Merck Partners with Blackstone to Advance Development of Investigational Cancer Therapy Sacituzumab Tirumotecan

Merck Partners with Blackstone to Advance Development of Investigational Cancer Therapy Sacituzumab Tirumotecan

Under the agreement, Blackstone will provide Merck with USD 700 million in non-refundable funding to support a portion of the development costs expected through 2026.

Merck Partners With Blackstone | 05/11/2025 | By Darshana


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members